LON:DNL

Diurnal Group News Headlines

GBX 67.50
-0.50 (-0.74 %)
(As of 05/7/2021 12:00 AM ET)
Add
Compare
Today's Range
67.06
68.80
50-Day Range
64
89
52-Week Range
28
97.98
Volume572,112 shs
Average Volume458,364 shs
Market Capitalization£93.38 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Headlines

Diurnal Group (LON DNL) News Headlines Today

SourceHeadline
Diurnal Group (LON:DNL) Trading Down 0.7%Diurnal Group (LON:DNL) Trading Down 0.7%
americanbankingnews.com - May 8 at 12:16 AM
Diurnal Group (LON:DNL) Stock Price Up 0.7%Diurnal Group (LON:DNL) Stock Price Up 0.7%
americanbankingnews.com - April 17 at 6:28 AM
Companies Like Diurnal Group (LON:DNL) Can Afford To Invest In GrowthCompanies Like Diurnal Group (LON:DNL) Can Afford To Invest In Growth
finance.yahoo.com - March 23 at 7:38 AM
Diurnal Reports Widened Loss In First Half Despite Revenue GrowthDiurnal Reports Widened Loss In First Half Despite Revenue Growth
lse.co.uk - February 23 at 8:13 AM
UPDATE: Diurnal Loss Widens In First Half; Signs Chronocort DealUPDATE: Diurnal Loss Widens In First Half; Signs Chronocort Deal
lse.co.uk - February 23 at 8:13 AM
When Can We Expect A Profit From Diurnal Group plc (LON:DNL)?When Can We Expect A Profit From Diurnal Group plc (LON:DNL)?
finance.yahoo.com - February 6 at 8:48 AM
Diurnal Inks Licence Agreement For Alkindi With Citrine MedicineDiurnal Inks Licence Agreement For Alkindi With Citrine Medicine
lse.co.uk - January 27 at 10:01 AM
Diurnal Group PLC : Agreement with Eton for Alkindi extended to CanadaDiurnal Group PLC : Agreement with Eton for Alkindi extended to Canada
markets.businessinsider.com - January 14 at 5:39 AM
What Kind Of Investors Own Most Of Diurnal Group plc (LON:DNL)?What Kind Of Investors Own Most Of Diurnal Group plc (LON:DNL)?
finance.yahoo.com - January 1 at 8:45 AM
Male Hypogonadism Market Global Trends, Market Share, Industry Size, Growth, Opportunities and Market Forecast 2020 to 2027Male Hypogonadism Market Global Trends, Market Share, Industry Size, Growth, Opportunities and Market Forecast 2020 to 2027
marketwatch.com - December 29 at 2:01 PM
5 Biopharma Stocks Making Big Moves Monday5 Biopharma Stocks Making Big Moves Monday
msn.com - December 14 at 3:39 PM
Key Things To Understand About Diurnal Groups (LON:DNL) CEO Pay ChequeKey Things To Understand About Diurnal Group's (LON:DNL) CEO Pay Cheque
finance.yahoo.com - November 26 at 8:37 AM
Diurnal Raises GBP8 Million For Product Development, CommercialisationDiurnal Raises GBP8 Million For Product Development, Commercialisation
lse.co.uk - October 9 at 12:36 PM
Hardman & Co Research: Diurnal (DNL): And then there were threeHardman & Co Research: Diurnal (DNL): And then there were three
uk.finance.yahoo.com - September 30 at 8:24 AM
Diurnal Grp Share ChatDiurnal Grp Share Chat
lse.co.uk - September 8 at 5:09 PM
The Diurnal Group (LON:DNL) Share Price Has Gained 68% And Shareholders Are Hoping For MoreThe Diurnal Group (LON:DNL) Share Price Has Gained 68% And Shareholders Are Hoping For More
finance.yahoo.com - September 1 at 9:07 AM
BRIEF-Diurnal Group Says Well-Positioned To Minimise Impact Of COVID-19BRIEF-Diurnal Group Says Well-Positioned To Minimise Impact Of COVID-19
www.reuters.com - April 15 at 9:46 AM
Hardman & Co Research: Diurnal (DNL): $52.5m US deal strengthens balance sheet furtherHardman & Co Research: Diurnal (DNL): $52.5m US deal strengthens balance sheet further
www.finanznachrichten.de - March 30 at 4:36 PM
Eton Pharmaceuticals Announces Acquisition of U.S Marketing Rights to Pediatric Orphan Drug Alkindi® SprinkleEton Pharmaceuticals Announces Acquisition of U.S Marketing Rights to Pediatric Orphan Drug Alkindi® Sprinkle
finance.yahoo.com - March 27 at 7:20 AM
BRIEF-Diurnal Group Has Raised About £11.2 Mln (Before Expenses) In AggregateBRIEF-Diurnal Group Has Raised About £11.2 Mln (Before Expenses) In Aggregate
www.reuters.com - March 26 at 5:22 AM
UPDATE: Diurnal Placing Raises GBP11 Million For Drug DevelopmentUPDATE: Diurnal Placing Raises GBP11 Million For Drug Development
www.lse.co.uk - March 6 at 2:08 PM
Diurnal Announces GBP7 Million Placing To Fund Drug DevelopmentDiurnal Announces GBP7 Million Placing To Fund Drug Development
www.lse.co.uk - March 6 at 9:08 AM
Diurnal Group Names Director Sam Williams Interim ChairDiurnal Group Names Director Sam Williams Interim Chair
www.lse.co.uk - March 5 at 2:31 PM
Hardman & Co Research: Diurnal (DNL): . and more to come (news flow)Hardman & Co Research: Diurnal (DNL): . and more to come (news flow)
www.finanznachrichten.de - February 28 at 3:40 AM
Diurnal Grp Regulatory NewsDiurnal Grp Regulatory News
www.lse.co.uk - February 13 at 10:21 PM
Diurnal Says US FDA Accepts New Drug Application For Alkindi SprinkleDiurnal Says US FDA Accepts New Drug Application For Alkindi Sprinkle
www.lse.co.uk - February 13 at 12:20 PM
Diurnal Loss Narrows In First Half Amid Improved Sales Of AlkindiDiurnal Loss Narrows In First Half Amid Improved Sales Of Alkindi
www.lse.co.uk - February 11 at 9:03 AM
BRIEF-Diurnal Group Says HY Alkindi Revenues Of £1.1 Mln, Representing 516% YOY GrowthBRIEF-Diurnal Group Says HY Alkindi Revenues Of £1.1 Mln, Representing 516% YOY Growth
www.reuters.com - February 11 at 9:03 AM
Diurnal narrows loss as it progresses drugs to marketDiurnal narrows loss as it progresses drugs to market
www.lse.co.uk - February 11 at 9:03 AM
Did Changing Sentiment Drive Diurnal Group's (LON:DNL) Share Price Down A Painful 71%?Did Changing Sentiment Drive Diurnal Group's (LON:DNL) Share Price Down A Painful 71%?
finance.yahoo.com - December 3 at 8:44 AM
Hardman & Co Research: Diurnal (DNL): Approaching a number of near-term milestonesHardman & Co Research: Diurnal (DNL): Approaching a number of near-term milestones
www.finanznachrichten.de - November 5 at 7:00 AM
What Did Diurnal Group plc's (LON:DNL) CEO Take Home Last Year?What Did Diurnal Group plc's (LON:DNL) CEO Take Home Last Year?
finance.yahoo.com - September 30 at 8:38 AM
Diurnal Loss Narrows On Research Expenses And Alkindi LaunchDiurnal Loss Narrows On Research Expenses And Alkindi Launch
www.lse.co.uk - September 24 at 8:16 AM
What Kind Of Shareholders Own Diurnal Group plc (LON:DNL)?What Kind Of Shareholders Own Diurnal Group plc (LON:DNL)?
finance.yahoo.com - July 12 at 4:39 PM
Diurnal Applies For Alkindi Market Authorisation In AustraliaDiurnal Applies For Alkindi Market Authorisation In Australia
www.morningstar.co.uk - July 3 at 10:38 AM
Change of AuditorChange of Auditor
markets.ft.com - June 21 at 8:16 AM
Diurnal Shareholders Approve Placing, Open Offer Worth GBP6 Million (ALLISS)Diurnal Shareholders Approve Placing, Open Offer Worth GBP6 Million (ALLISS)
www.morningstar.co.uk - June 14 at 12:40 PM
Diurnal Raises GBP5 Million Via Placing; Plans GBP1 Million Open Offer (ALLISS)Diurnal Raises GBP5 Million Via Placing; Plans GBP1 Million Open Offer (ALLISS)
www.morningstar.co.uk - May 28 at 10:24 AM
Diurnal Gets Orphan Drug Designation For Alkindi In AustraliaDiurnal Gets Orphan Drug Designation For Alkindi In Australia
www.morningstar.co.uk - April 24 at 10:43 AM
IP Group Pleased As Diurnal Gets Positive EMA Feedback For ChronocortIP Group Pleased As Diurnal Gets Positive EMA Feedback For Chronocort
www.morningstar.co.uk - April 11 at 12:04 PM
Diurnal Gets New Israel Alkindi Patent; Market Application SubmittedDiurnal Gets New Israel Alkindi Patent; Market Application Submitted
www.morningstar.co.uk - February 25 at 5:10 PM
Hardman & Co Research: Diurnal Group (DNL): Chronocort - seeking regulatory adviceHardman & Co Research: Diurnal Group (DNL): Chronocort - seeking regulatory advice
www.finanznachrichten.de - January 16 at 10:14 AM
Diurnal Shares Surge As Secures Second Patent For Chronocort In USDiurnal Shares Surge As Secures Second Patent For Chronocort In US
www.morningstar.co.uk - January 10 at 10:52 AM
Diurnal Granted US Patent But Unsure Why Share Price Has TripledDiurnal Granted US Patent But Unsure Why Share Price Has Tripled
www.morningstar.co.uk - January 10 at 10:52 AM
This page was last updated on 5/8/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.